Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Tezign | Shanghai | Series D | $40.0M | 2021-10-25 |
| SynMetaBio | Shanghai | Series A | $14.7M | 2026-07-06 |
| Dishi Medical | Hangzhou | Series A | $13.7M | 2026-01-19 |
| BOOLV | Shenzhen | Series A | $10.0M | 2022-03-01 |
| Supremind | Shanghai | Series C | $59.2M | 2022-08-09 |
| YRobot | Suzhou | Series A | $10.0M | 2021-04-22 |
| ACXEL Tech | Foshan | Series A | $14.1M | 2024-01-01 |
7 rows of the CSV in 5 of its 18 columns.
- The 20 Linear Capital portfolio companies have raised $52.8M in total.
- 3 of them closed their most recent round in the last 12 months, $28.4M combined.
- The largest of those rounds is SynMetaBio's $14.7M Series A, dated July 2026.
- Linear Venture is an investor in 5 of them, more than any other fund.
- Software is the most common sector, with 14 companies (70%).
- 55% were founded in 2020 or later; the median founding year is 2020.
- The most common team size is 11 to 50 employees (61% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 20| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| SynMetaBio | SynMetaBio develops synthetic biological materials by combining synthetic biology with material design. | Biotech | Shanghai, China | Series A | $14.7M | 2026-07-06 | $16.1M | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2021 |
| Dishi Medical | Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. | Biotech | Hangzhou, China | Series A | $13.7M | 2026-01-19 | $13.7M | Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 | 11 to 50 | 2021 |
| Meiyou Technology | Meiyou Technology develops DNA synthesizers using enzymatic technology for long-fragment DNA synthesis and splicing. | Biotech | Shanghai, China | Angel | $1.4M | 2024-06-28 | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2023 | |
| ACXEL Tech | ACXEL Tech develops a digital microfluidic large area electronic platform for cell manipulation. | Hardware | Foshan, China | Series A | $14.1M | 2024-01-01 | Qiming Venture Partners, Cowin Capital, Hillhouse Ventures +1 | 51 to 100 | 2021 | |
| Tezign Unicorn | Tezign provides a content and AI platform that helps enterprises produce, manage, distribute, and analyze content. | Software | Shanghai, China | Series D | $40.0M | 2021-10-25 | Temasek, Cherubic Ventures, Linear Venture +1 | 101 to 250 | 2015 |
Table 1. Linear Capital portfolio companies: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SynMetaBio | SynMetaBio develops synthetic biological materials by combining synthetic biology with material design. | Biotech | Shanghai, China | Series A | $14.7M | 2026-07-06 | $16.1M | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2021 |
| 2 | Dishi Medical | Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. | Biotech | Hangzhou, China | Series A | $13.7M | 2026-01-19 | $13.7M | Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 | 11 to 50 | 2021 |
Table 2. Linear Capital portfolio companies: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Linear Venture | Venture capital firm | Shanghai, China | 5 | 25% | ||
| 2 | MiraclePlus | Startup accelerator | Haidian, China | 2 | 10% | 1 | SynMetaBio |
| 3 | Danen Capital | Venture capital firm | Shenzhen, China | 2 | 10% | 1 | SynMetaBio |
| 4 | Hillhouse Investment | Angel group | Singapore | 2 | 10% | 1 | Dishi Medical |
| 5 | GL Ventures LLC | Venture capital firm | Beijing, China | 2 | 10% | ||
| 6 | Baidu Ventures | Venture capital firm | Beijing, China | 2 | 10% | ||
| 7 | Koala Fund | Hedge fund | Haidian, China | 2 | 10% | ||
| 8 | Temasek | Private equity firm | Singapore | 1 | 5% | ||
| 9 | Cherubic Ventures | Venture capital firm | Taipei, Taiwan | 1 | 5% | ||
| 10 | SOSV | Venture capital firm | Princeton, United States | 1 | 5% | ||
| 11 | 500 Global | Startup accelerator | Palo Alto, United States | 1 | 5% | ||
| 12 | Artesian VC | Venture capital firm | Melbourne, Australia | 1 | 5% | ||
| 13 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 1 | 5% | 1 | Dishi Medical |
| 14 | Infinity Equity | Private equity firm | Wan Chai, Hong Kong | 1 | 5% | 1 | Dishi Medical |
| 15 | Decent Capital | Venture capital firm | Palo Alto, United States | 1 | 5% |
Table 3. Linear Capital portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 14 | 70% | $22.9M |
| Artificial intelligence | 8 | 40% | $22.9M |
| Hardware | 6 | 30% | $22.9M |
| Biotech | 4 | 20% | $29.8M |
| Health care | 3 | 15% | $13.7M |
| Energy | 1 | 5% |
Table 4. Linear Capital portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Linear Capital portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
Table 6. Linear Capital portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Linear Capital portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| July 2026 | 1 | 33% | $14.7M |
| January 2026 | 1 | 33% | $13.7M |
| December 2025 | 1 | 33% |
Table 8. Linear Capital portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 2 | 10% | $28.4M |
| 2025 | 2 | 10% | |
| 2024 | 2 | 10% | $15.5M |
| 2023 | 6 | 30% | $3.5M |
| 2022 | 5 | 25% | $69.2M |
| 2021 | 2 | 10% | $50.0M |
Table 9. Linear Capital portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 10% |
| 2020 to 2022 | 9 | 45% |
| 2015 to 2019 | 9 | 45% |
Table 10. Linear Capital portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 11 to 50 | 11 | 61% |
| 51 to 100 | 4 | 22% |
| 101 to 250 | 3 | 17% |
Table 11. Linear Capital portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Linear Capital is recorded as one of its investors. On 16 November 2026 that is 20 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 20 rows: 11 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many Linear Capital portfolio companies are on the list?
- 20, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.